🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ORI
$ORIC
🔒 US EquitiesORIC Pharmaceuticals Inc
AVG HISTORICAL GAP
+1.36%
MAX GAP RECORD
+9.17%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ORIC
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ORIC
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 03, 2026 Earnings Release 2026-08-03 (AFTER CLOSE) |
+0.38%
|
| May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE) |
+1.04%
|
| Feb 23, 2026 Earnings Release 2026-02-23 (AFTER CLOSE) |
+3.16%
|
| Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE) |
+2.05%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
+0.42%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+2.18%
|
| Feb 18, 2025 Earnings Release 2025-02-18 (AFTER CLOSE) |
+9.17%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-0.29%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.4%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (5)
📖 Intelligence Summary
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗